L-fucose and fucoidan alleviate high-salt diet-promoted acute inflammation
Open Access
- 26 March 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1333848
Abstract
Excessive salt intake is a widespread health issue observed in almost every country around the world. A high salt diet (HSD) has a strong correlation with numerous diseases, including hypertension, chronic kidney disease, and autoimmune disorders. However, the mechanisms underlying HSD-promotion of inflammation and exacerbation of these diseases are not fully understood. In this study, we observed that HSD consumption reduced the abundance of the gut microbial metabolite L-fucose, leading to a more substantial inflammatory response in mice. A HSD led to increased peritonitis incidence in mice, as evidenced by the increased accumulation of inflammatory cells and elevated levels of inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and monocyte chemotactic protein-1 (MCP-1, also known as C-C motif chemokine ligand 2 or CCL2), in peritoneal lavage fluid. Following the administration of broad-spectrum antibiotics, HSD-induced inflammation was abolished, indicating that the proinflammatory effects of HSD were not due to the direct effect of sodium, but rather to HSD-induced alterations in the composition of the gut microbiota. By using untargeted metabolomics techniques, we determined that the levels of the gut microbial metabolite L-fucose were reduced by a HSD. Moreover, the administration of L-fucose or fucoidan, a compound derived from brown that is rich in L-fucose, normalized the level of inflammation in mice following HSD induction. In addition, both L-fucose and fucoidan inhibited LPS-induced macrophage activation in vitro. In summary, our research showed that reduced L-fucose levels in the gut contributed to HSD-exacerbated acute inflammation in mice; these results indicate that L-fucose and fucoidan could interfere with HSD-promotion of the inflammatory response.Keywords
Funding Information
- National Natural Science Foundation of China (82071778, 32000638)
This publication has 67 references indexed in Scilit:
- Sodium and its manifold impact on our immune systemTrends in Immunology, 2021
- Human gut microbiota/microbiome in health and diseases: a reviewAntonie van Leeuwenhoek, 2020
- L-Fucose ameliorates DSS-induced acute colitis via inhibiting macrophage M1 polarization and inhibiting NLRP3 inflammasome and NF-kB activationInternational Immunopharmacology, 2019
- Commensal bacteria modulate the tumor microenvironmentCancer Letters, 2016
- Brief Report: Dialister as a Microbial Marker of Disease Activity in SpondyloarthritisArthritis & Rheumatology, 2016
- Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiotaMolecular Nutrition & Food Research, 2016
- Toll-Like Receptors Expression and NF-κB Activation in Peritoneal Leukocytes in Morphine-Mediated Impairment of Zymosan-Induced Peritonitis in Swiss MiceArchivum Immunologiae et Therapiae Experimentalis, 2012
- Molecular characteristics and anti-inflammatory activity of the fucoidan extracted from Ecklonia cavaCarbohydrate Polymers, 2012
- Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-κB pathwaysThe International Journal of Biochemistry & Cell Biology, 2008
- l-Fucose blocks MIF/MAF priming of rabbit alveolar macrophages for a PMA-induced oxidative responseCellular Immunology, 1989